Clinical Trials Logo

Prediabetic State clinical trials

View clinical trials related to Prediabetic State.

Filter by:

NCT ID: NCT03919877 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Precision Diets for Diabetes Prevention

Start date: May 24, 2018
Phase: N/A
Study type: Interventional

With this study the investigators want to understand the physiological differences for people developing pre-diabetes and diabetes. The investigators hypothesize that different individuals go through different paths in the development of the disease. By understanding the personal mechanism for developing disease, the investigators will find a personalized approach to prevent that development. The investigators are also hoping to be able to find a biomarker that will pinpoint to the particular defect and thus, diagnose the problem at an earlier stage and have the information to give personalized diet recommendations to prevent the development of diabetes more effectively.

NCT ID: NCT03917784 Recruiting - PreDiabetes Clinical Trials

Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes

Start date: February 25, 2019
Phase: Phase 4
Study type: Interventional

This study evaluates the effects of oral supplementation with curcumin on the insulin sensitivity in subjects with prediabetes. The half of participants will receive curcumin and bioperine in combination, while the other half receive placebo.

NCT ID: NCT03914924 Recruiting - Diabetes Mellitus Clinical Trials

Effects of an Exercise and Lifestyle Education Program for People With Diabetes and Prediabetes

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this trial is to pragmatically investigate whether participation of people with diabetes and prediabetes in an Exercise and Lifestyle Education Program (i.e., exercise and education classes) results in better functional capacity, disease-related knowledge and behavior, and cardiometabolic health parameters when compared to Exercise Program (i.e., exercise class only). In addition, the effects of these interventions will be evaluated on other outcomes: program adherence, satisfaction with the program, quality of life, diet quality, depression, and morbidity associated with diabetes in the 6-month follow-up.

NCT ID: NCT03906201 Recruiting - PreDiabetes Clinical Trials

Effect of Phytoecdysterone Administration in Subjects With Prediabetes

Start date: February 6, 2019
Phase: N/A
Study type: Interventional

Prediabetes is the term used for people whose glucose levels do not meet the criteria for diabetes but are too high to be considered normal. This is defined by the presence of blood glucose between 100-125 mg / dL, values per glucose tolerance curve of 140-199mg / dL and/or HbA1c 5.7-6.4%. Prediabetes should not be considered as a clinical entity in itself, but as a risk factor for diabetes and cardiovascular disease (CVD). Prediabetes is associated with obesity (especially abdominal or visceral obesity), dyslipidemia with elevated triglycerides and/or low HDL cholesterol, and hypertension.

NCT ID: NCT03901248 Completed - Clinical trials for Type2 Diabetes Mellitus

Study of Association of Salivary Adipokines With Prediabetes and Type 2 Diabetes Mellitus

Start date: July 2015
Phase:
Study type: Observational

India has more than 65 million adults with Type 2 Diabetes Mellitus (T2DM) and also has a large number with subclinical stages of glycaemia including impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). At present people with high risk of diabetes are identified by blood test such as Oral glucose tolerance Test and/or glycosylated haemoglobin A1c (HbA1c). Dysregulated actions of adipokines have major roles in development of metabolic diseases such as diabetes. Adipokines influence systemic insulin resistance and also regulate inflammatory process and/or are likely to have major pathological role in the development of diabetes. It is also likely that these abnormalities occur even in sub clinical stages of T2DM which when identified would provide an early opportunity to institute early intervention using life style changes which are proven to be effective in all ethnic groups.The measurements of adipokines such as adiponectin, apelin, visfatin and vaspin which have inter related regulatory roles, in saliva if found to be sensitive would provide a non-invasive, simple method of assessing persons with high risk of T2DM.

NCT ID: NCT03896360 Completed - Obesity Clinical Trials

Study of the Food Order Behavioral Intervention in Prediabetes

Start date: February 28, 2019
Phase: N/A
Study type: Interventional

Investigators have previously shown that eating carbohydrates after protein or vegetables resulted in reduced glucose and insulin excursions over 180 min in patients with T2DM and in individuals with prediabetes as well. This is an open label, randomized controlled pilot study to assess the efficacy of carbohydrate-last food order behavior in reducing the risk of progression to type 2 diabetes (T2DM).

NCT ID: NCT03889977 Completed - Clinical trials for Diabetes Mellitus, Type 2

Resistance Exercise on Postprandial Hyperglycemia in Patients With B-thalassemia Exhibiting Resistance to Insulin

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

It is known that postprandial hyperglycemia increases the cardiometabolic risk in both diabetic and non-diabetic patients. Moreover, there is insufficient data on the effectiveness of exercise on preventing Type II diabetes mellitus in individuals with insulin resistance and prediabetes. This study aims to examine the effectiveness of resistance exercise in limiting postprandial hyperglycemia and the necessity of prescribing medication particularly in patients with beta-thalassemia and insulin resistance.

NCT ID: NCT03889210 Completed - PreDiabetes Clinical Trials

β-hydroxybutyrate, Glucose Metabolism and Prediabetes

CETUS
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The study aims to investigate changes in blood glucose metabolism after administration of a ketone ester drink.

NCT ID: NCT03884920 Completed - Diabetes Mellitus Clinical Trials

Glucose Tolerance and Prevention of Diabetes Mellitus Type 2 by Polyherbal Formulation

Phase-1
Start date: March 20, 2019
Phase:
Study type: Observational

Primary protocol to this study is to develop a natural remedy to prevent diabetes mellitus in pre-diabetic state and elaborate the effectiveness of polyherbal formulation for carrying out Phase-II, III and IV. It also aimed at to see the level of difference of glucose tolerance and impaired fasting glucose and impaired glucose tolerance between pre-diabetic and diabetic to evaluate the potential benefit for treatment of insulin resistance and sensitivity. To see the for prevention of Diabetes Mellitus (DM) and stopping / delaying the onset of DM.

NCT ID: NCT03880162 Active, not recruiting - PreDiabetes Clinical Trials

Metabolic Effects of a Low Carbohydrate Versus a Standard Diet in Morbidly Obese With Prediabetes

CaPrO
Start date: May 13, 2019
Phase: N/A
Study type: Interventional

To investigate the metabolic effects of a low carbohydrate versus energy-matched standard diet in morbidly obese individuals with prediabetes awaiting bariatric surgery.